United Therapeutics Corporation (UTHR): A Bull Case Theory
We came across a bullish thesis on United Therapeutics Corporation on BioEquity Watch’s Substack. In this article, we will summarize the […]
Therapeutics
Featured
Form 144 MAZE THERAPEUTICS For: 6 January
Form 144 MAZE THERAPEUTICS For: 6 January Source link
Viking Therapeutics: A Wide-Open Oral GLP-1 Market
Viking Therapeutics: A Wide-Open Oral GLP-1 Market Source link
Why Vera Therapeutics Stock Crushed it Today
If all goes well, the company will have a drug on the market that could bring in billions of dollars
MiNK Therapeutics (INKT) Earnings Call Transcript
Image source: The Motley Fool. DATE Friday, November 14, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer —
Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares?
Venture capital fund Third Rock Ventures IV, L.P., a 10% owner of Tango Therapeutics, Inc. (TNGX +1.79%), reported the sale
Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics
Naples, FL, September 26th, 2025, FinanceWire Naples, FL, September 26th, 2025, NewsDirect Biotech is entering a new era of drug
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
Austin, Texas, United States, September 9th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that its wholly
Why Viking Therapeutics Stock Popped Nearly 4% Today
Numerous companies in the healthcare sector are feverishly busy developing obesity drugs, as these products have taken the medical world
PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital
PTC Therapeutics (PTCT) on Tuesday announced that they received a complete response letter for vatiquinone in Friedreich’s ataxia, with the